Medicine and Dentistry
Haemophilia A
83%
Bleeding Disorder
62%
Von Willebrand Disease
43%
Pharmacokinetics
37%
Bleeding
35%
Von Willebrand Factor
26%
Desmopressin
25%
Sickle-Cell Disease
25%
Blood Clotting Factor 8
21%
Patient-Reported Outcome
17%
Pediatrics
15%
Diseases
14%
Haemophilia B
13%
Outcome Assessment
13%
Blood Clotting Factor 8 Concentrate
12%
Quality of Life
11%
Platelet
11%
Thrombocyte Function
11%
Disease
11%
Prevalence
9%
Hemostat
8%
Randomized Controlled Trial
8%
Health Outcomes
8%
Systematic Review
8%
Psychometry
8%
Biological Marker
8%
Health Care Provider
8%
Ciclonicate
7%
Menorrhagia
7%
Blood Stasis
7%
Substitution Therapy
6%
Cross Sectional Study
6%
Adenosine Triphosphate
6%
Erythrocyte
5%
Lochia
5%
Pyruvate Kinase
5%
Hemarthrosis
5%
Blood Clotting Factor
5%
Odds Ratio
5%
Magnetic Resonance Imaging
5%
Prospective Study
5%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
100%
Haemophilia A
90%
Blood Clotting Factor 8
55%
Blood Clotting Factor 8 Concentrate
34%
Bleeding
29%
Von Willebrand Factor
28%
Von Willebrand Disease
24%
Haemophilia B
19%
Desmopressin
17%
Blood Clotting Factor 9
14%
Pharmacokinetic Parameter
13%
Replacement Therapy
13%
Sickle Cell Anemia
12%
Pharmacodynamics
12%
Bleeding Disorder
11%
Blood Clotting Factor 9 Concentrate
11%
Pharmacokinetic Modeling
8%
Randomized Controlled Trial
8%
Emicizumab
8%
Plasmin
8%
Thrombin
8%
Blood Clotting Factor Concentrate
8%
Trough Level
7%
Ciclonicate
6%
Chimeric Protein
6%
Blood Clotting Factor
6%
Prospective Study
5%
Biochemistry, Genetics and Molecular Biology
Von Willebrand Disease
35%
Von Willebrand Factor
28%
Haemophilia A
21%
Pharmacokinetics
17%
Pyruvate Kinase
14%
Desmopressin
13%
Genetic Divergence
13%
Platelet
12%
Factor VIII
12%
Adenosine Triphosphate
10%
Hemocyte
9%
Haemophilia B
8%
Factor IX
6%
Genotyping
6%
Fibrinogen
5%
Secretion (Process)
5%